StockPriceToday
Varonis Systems Inc. (VRNS)
About Varonis Systems Inc.
Varonis Systems Inc., founded in 2005, has become a leader in data security and governance solutions, helping organizations understand and protect their most sensitive data across diverse IT environments. The company's platform provides comprehensive data visibility and protection capabilities. VRNS stock price reflects the company's technology leadership and the growing importance of data security and privacy compliance.
Led by CEO Yaki Faitelson, who co-founded the company, Varonis has successfully expanded from data access governance to comprehensive data security while building cloud-native capabilities. The management team has focused on innovation and market expansion while maintaining high customer satisfaction and retention rates. Leadership's vision for data-centric security has been instrumental in building market leadership and driving VRNS stock price appreciation.
Varonis operates by providing software platforms that discover, classify, monitor, and protect sensitive data across file systems, databases, cloud storage, and collaboration platforms. The company generates revenue through software subscriptions and professional services while serving enterprises globally. With data breaches and privacy regulations driving demand for data security solutions, increasing data volumes requiring automated governance and protection, and Varonis' established technology leadership and customer relationships, VRNS offers investors exposure to essential cybersecurity infrastructure with strong recurring revenue characteristics and significant growth potential as data security becomes increasingly critical for organizations worldwide.
VRNS Stock 12 Month Chart
Latest News for VRNS
Varonis' Q3 report arrived with an earnings beat, but sales missed expectations. The company issued weak Q4 guidance and lowered key full-year targets. Varonis issued a significant downward revision ...
Other Popular Stocks
Terns Pharmaceuticals Inc. (TERN) is a clinical-stage biopharmaceutical company developing innovative therapies for chronic liver diseases, focusing on treatments for NASH, liver fibrosis, and...
Analog Devices Inc. designs, manufactures, tests, and markets integrated circuits, software, and subsystems that leverage analog, mixed-signal, and digital signal processing technologies worldwide.
Atlanticus Holdings Corporation provides credit and related financial services and products to underbanked consumers through technology platforms.